Ropivacaine Hydrochloride Patent Expiration
Ropivacaine Hydrochloride is used for pain management. It was first introduced by Fresenius Kabi Usa Llc
Ropivacaine Hydrochloride Patents
Given below is the list of patents protecting Ropivacaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Naropin | US7857802 | Connector for medical liquid-containing packages and medical liquid-containing packages | Nov 28, 2026 | Fresenius Kabi Usa |
| Naropin | US7828787 | Connector for packaging containing medical fluids and packaging for medical fluids | Oct 18, 2025 | Fresenius Kabi Usa |
| Naropin | US8162915 | Connector for packings containing medical liquids, and corresponding packing for medical liquids |
May 23, 2024
(Expired) | Fresenius Kabi Usa |
| Naropin | US8118802 | Connector for packaging containing medical fluids and packaging for medical fluids |
May 18, 2023
(Expired) | Fresenius Kabi Usa |
| Naropin | US5670524 | Methods and compositions for the treatment of pain utilizing ropivacaine |
Sep 23, 2014
(Expired) | Fresenius Kabi Usa |
| Naropin | US5834489 | Methods and compositions for the treatment of pain utilizing ropivacaine |
May 26, 2014
(Expired) | Fresenius Kabi Usa |
Ropivacaine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List